Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 8/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | TFPI | P10646 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30721650 | 0.97 | OPRM1 (0.55) | OPRL1OPRM1OPRD1OPRK1TFPI | |
| SCHEMBL29436306 | 0.93 | OPRM1 (0.54) | OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL30974061 | 0.91 | OPRL1 (0.59) | OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL29674783 | 0.90 | OPRM1 (0.53) | OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL30467092 | 0.90 | TFPI (0.62) | OPRM1OPRD1OPRK1TFPI | |
| SCHEMBL29436286 | 0.89 | OPRM1 (0.55) | OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL29375389 | 0.88 | BACE1 (0.56) | OPRM1OPRD1 | |
| SCHEMBL29375740 | 0.88 | BACE1 (0.56) | OPRM1OPRD1 | |
| SCHEMBL30974017 | 0.88 | OPRL1 (0.62) | OPRL1OPRM1OPRD1OPRK1 | |
| SCHEMBL30974537 | 0.87 | OPRL1 (0.58) | OPRL1OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724472-A2 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2026-04-15 | — | — | EP | claimed |
| WO-2024252367-A2 | NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-12-12 | — | — | WO | claimed |
| EP-4724472-A2 | GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024252367-A2 | NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-12-12 | — | — | WO | disclosed |